Please try another search
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Brian McKelligon | 53 | 2017 | President, CEO & Director |
Thomas A. Raffin | 75 | 2015 | Director |
Matthew Winkler | 70 | 2017 | Independent Director |
Thomas Patrick Schnettler | 65 | 2019 | Independent Director |
Scott Edward Mendel | 55 | 2021 | Independent Director |
Myla P. Lai-Goldman | 64 | 2021 | Independent Director |
Padmanee Sharma | - | - | Member of Scientific Advisory Board |
James Patrick Allison | - | - | Member of Scientific Advisory Board |
Garry P. Nolan | 62 | 2015 | Chair of the Scientific Advisory Board |
Robert G. Shepler | 66 | 2015 | Independent Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review